期刊文献+

晚期胰腺癌区域性动脉灌注化疗25例临床分析 被引量:1

Clinical analysis of twenty-five cases with advanced pancreatic carcinoma treated by arterial infusion regional chemoherapy
下载PDF
导出
摘要 目的探讨晚期胰腺癌区域性动脉灌注化疗的有效性。方法采用单管或多管动脉插管为25例晚期不能切除胰腺癌患者进行区域性灌注化疗。结果25例患者均有不同程度腹痛、腹胀减轻,黄疸消退,体质量上升。术前需要镇痛治疗10例,其中9例停用镇痛药,1例减量,随访23例,平均生存期16个月。结论区域性动脉灌注化疗为晚期不可切除胰腺癌患者提供一个新的比较有效的治疗方法,他可以减轻患者的症状,延缓肿瘤生长速度,延长患者生存期。 Objective To explore the efficacy of arterial infusion chemotherapy (AIRC)on advanced pancreatic carcinoma. Methods Twenty-five patients with advanced pancreatic carcinoma which could not be excised were given arterial infusion regional chemotherapy by one or more catheters. Results All thepatients' symptoms such as abdominal pain, distension were alleviated in different level, jaundice disappeared, the patients' weight increased. Ten patients depended on analgesics reduced in the other one. Following-up twentythree months, the average survival time was sixteen months. Conclusion Arterial infusion regional chemotherapy provides a new and effective therapy method for advanced pancreatic carcinoma. It can alleviate the clinical symptoms, postpone the growth speed of tumor and prolong the survival time of the patients
作者 李大志
出处 《中国实用医药》 2009年第17期108-109,共2页 China Practical Medicine
关键词 晚期胰腺癌 动脉区域性化疗 生存期 Advanced pancreatic carcinoma Arterial infusion regional chemotherapy Average survival time
  • 相关文献

参考文献2

二级参考文献14

  • 1[1]Ghaneh P,Kawesha A,Howes N,et al.Adjuvant therapy for pancreatic cancer.World J Surg,1999,23(9):937
  • 2[2]Beger HG,Gansauge F,Buchler MW,et al.Intraarterial adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic cancer:significant reduction in occurrence of liver metastasis .World J Surg,1999,23(9):946
  • 3[3]Thomford NR,Chandnani PC,Taha AM,et al.Anatomic characteristics of the pancreatic arteries:radiologic observation and their clinical significance.Am J Surg,1986,151(6):690
  • 4[4]Bertelli E,Di Gregorio F,Mosca S,et al.The arterial blood supply of the pancreas:a review.Ⅴ.The dorsal pancreatic artery.An anatomic review and a radiologic study.Surg Radiol Anat,1998,20(6):445
  • 5[5]Homma H,Doi T,Mezawa S,et al.A novel arterial infusion chemotherapy for the treatment of patients with advanced pancreatic carcinoma after vascular supply distribution via superselective embolization.Cancer,2000,89(2):303
  • 6[6]Yoshida H,Iguchi C,Yamasawa K,et al.New techniques:splenic artery embolization followed by intraarterial infusion chemotherapy for the treatment of pancreatic cancer.Hepatogastroenterology,1999,46(27):2024
  • 7[7]Lorenz M,Heinrich S,Staib-Sebler E,et al.Regional chemotherapy in the treatment of advanced pancreatic cancer-is it relevent?Eur J Cancer,2000,36(8):957
  • 8[8]Klapdor R,Muller C,Seutter R,et al.Improvement of survival by efficacy orientated sequential polychemotherapy of exocrine pancreatic cacner.Anticancer Res,2000,20(6D)5201
  • 9[9]Ozaki H,Kinoshita T,Kosuge T,et al.Long-term survival after multimodality treatment for resectable pancreatic cancer.Int J Pancreatol,2000,27(3):217
  • 10[11]Lorenz M,Petrowsky H,Heinrich S,et al.Isolated hypoxic perfusion with mitomycin C in patients with advanced pancreatic cancer.Eur J Surg Oncol,1998,24(6):542

共引文献5

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部